Correlation Between XOMA Corp and Dyne Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XOMA Corp and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XOMA Corp and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XOMA Corp and Dyne Therapeutics, you can compare the effects of market volatilities on XOMA Corp and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XOMA Corp with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of XOMA Corp and Dyne Therapeutics.

Diversification Opportunities for XOMA Corp and Dyne Therapeutics

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between XOMA and Dyne is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding XOMA Corp and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and XOMA Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XOMA Corp are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of XOMA Corp i.e., XOMA Corp and Dyne Therapeutics go up and down completely randomly.

Pair Corralation between XOMA Corp and Dyne Therapeutics

Given the investment horizon of 90 days XOMA Corp is expected to under-perform the Dyne Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, XOMA Corp is 1.52 times less risky than Dyne Therapeutics. The stock trades about -0.25 of its potential returns per unit of risk. The Dyne Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1,346  in Dyne Therapeutics on November 29, 2024 and sell it today you would earn a total of  33.00  from holding Dyne Therapeutics or generate 2.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

XOMA Corp  vs.  Dyne Therapeutics

 Performance 
       Timeline  
XOMA Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days XOMA Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Dyne Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

XOMA Corp and Dyne Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with XOMA Corp and Dyne Therapeutics

The main advantage of trading using opposite XOMA Corp and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XOMA Corp position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.
The idea behind XOMA Corp and Dyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets